Profile of Co-morbidities in the Obese

by Salati SA, Kadi AA
Published 2015-07-01

Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach

by Abdelhameed AS, Attwa MW, Kadi AA
Published 2020-11-01

LC–MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation

by Attwa MW, Abdelhameed AS, Kadi AA
Published 2021-09-01

Metabolic Stability Assessment of Larotrectinib Using Liquid Chromatography Tandem Mass Spectrometry

by Attwa MW, Kadi AA, Darwish HW
Published 2020-01-01

Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies

by Attwa MW, Kadi AA, Abdelhameed AS, Alhazmi HA
Published 2020-02-01

LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay

by Attwa MW, Abdelhameed AS, Al-Shakliah NS, Kadi AA
Published 2020-10-01

A New Validated HPLC-MS/MS Method for Quantification and Pharmacokinetic Evaluation of Dovitinib, a Multi-Kinase Inhibitor, in Mouse Plasma

by AlRabiah H, Kadi AA, Aljohar HI, Attwa MW, Al-Shakliah NS, Attia SM, Mostafa GAE
Published 2020-01-01

Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling

by Abdel-Aziz HA, Eldehna WM, Keeton AB, Piazza GA, Kadi AA, Attwa MW, Abdelhameed AS, Attia MI
Published 2017-08-01